Lenzi R - Search Results

1

5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer.

Li D, Ahmed M, Li Y, Jiao L, Chou TH, Wolff RA, Lenzi R, Evans DB, Bondy ML, Pisters PW, Abbruzzese JL, Hassan MM. Li D, et al. Among authors: lenzi r. Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1470-6. doi: 10.1158/1055-9965.EPI-04-0894. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15941958

2

Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer.

Li D, Jiao L, Li Y, Doll MA, Hein DW, Bondy ML, Evans DB, Wolff RA, Lenzi R, Pisters PW, Abbruzzese JL, Hassan MM. Li D, et al. Among authors: lenzi r. Carcinogenesis. 2006 Jan;27(1):103-11. doi: 10.1093/carcin/bgi171. Epub 2005 Jun 29. Carcinogenesis. 2006. PMID: 15987714 Free PMC article.

3

Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case-control study.

Hassan MM, Abbruzzese JL, Bondy ML, Wolff RA, Vauthey JN, Pisters PW, Evans DB, Khan R, Lenzi R, Jiao L, Li D. Hassan MM, et al. Among authors: lenzi r. Cancer. 2007 Jun 15;109(12):2547-56. doi: 10.1002/cncr.22724. Cancer. 2007. PMID: 17492688 Free PMC article.

4

Risk factors for pancreatic cancer: case-control study.

Hassan MM, Bondy ML, Wolff RA, Abbruzzese JL, Vauthey JN, Pisters PW, Evans DB, Khan R, Chou TH, Lenzi R, Jiao L, Li D. Hassan MM, et al. Among authors: lenzi r. Am J Gastroenterol. 2007 Dec;102(12):2696-707. doi: 10.1111/j.1572-0241.2007.01510.x. Epub 2007 Aug 31. Am J Gastroenterol. 2007. PMID: 17764494 Free PMC article.

5

Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma.

Wolff RA, Evans DB, Gravel DM, Lenzi R, Pisters PW, Lee JE, Janjan NA, Charnsangavej C, Abbruzzese JL. Wolff RA, et al. Among authors: lenzi r. Clin Cancer Res. 2001 Aug;7(8):2246-53. Clin Cancer Res. 2001. PMID: 11489798 Clinical Trial.

6

Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome.

Pisters PW, Wolff RA, Janjan NA, Cleary KR, Charnsangavej C, Crane CN, Lenzi R, Vauthey JN, Lee JE, Abbruzzese JL, Evans DB. Pisters PW, et al. Among authors: lenzi r. J Clin Oncol. 2002 May 15;20(10):2537-44. doi: 10.1200/JCO.2002.11.064. J Clin Oncol. 2002. PMID: 12011133

7

Phase II study of docetaxel in patients with pancreatic cancer previously untreated with cytotoxic chemotherapy.

Lenzi R, Yalcin S, Evans DB, Abbruzzese JL. Lenzi R, et al. Cancer Invest. 2002;20(4):464-72. doi: 10.1081/cnv-120002146. Cancer Invest. 2002. PMID: 12094541 Clinical Trial.

8

Diagnostic strategies for unknown primary cancer.

Varadhachary GR, Abbruzzese JL, Lenzi R. Varadhachary GR, et al. Among authors: lenzi r. Cancer. 2004 May 1;100(9):1776-85. doi: 10.1002/cncr.20202. Cancer. 2004. PMID: 15112256 Free article. Review.

9

A pharmacological study of celecoxib and gemcitabine in patients with advanced pancreatic cancer.

Xiong HQ, Plunkett W, Wolff R, Du M, Lenzi R, Abbruzzese JL. Xiong HQ, et al. Among authors: lenzi r. Cancer Chemother Pharmacol. 2005 Jun;55(6):559-64. doi: 10.1007/s00280-004-0916-9. Epub 2005 Feb 22. Cancer Chemother Pharmacol. 2005. PMID: 15726370 Clinical Trial.

10

Metastatic patterns in adenocarcinoma.

Hess KR, Varadhachary GR, Taylor SH, Wei W, Raber MN, Lenzi R, Abbruzzese JL. Hess KR, et al. Among authors: lenzi r. Cancer. 2006 Apr 1;106(7):1624-33. doi: 10.1002/cncr.21778. Cancer. 2006. PMID: 16518827 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

224 results

Search Page